Witte Owen N. (CIK 0001700969)

Latest company ownership

Shares held
191,082
Last filed at
Jun 7, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 11, 2022 Aug 15, 2022 Allogene Therapeutics, Inc. Director Sell 20.0 -15,000 -6.43% ✗ $251.3K
Aug 11, 2022 Aug 15, 2022 Allogene Therapeutics, Inc. Director Sell 20.0 -15,000 -6.43% ✗ $251.3K
Jun 22, 2022 Jun 23, 2022 Allogene Therapeutics, Inc. Director Sell 22.5 -10,000 -4.11% ✗ $117.6K
Sep 9, 2021 Sep 9, 2021 Allogene Therapeutics, Inc. Director Sell 22.5 -5,000 -2.21% ✗ $127.7K
Aug 20, 2021 Aug 23, 2021 Allogene Therapeutics, Inc. Director Sell 22.5 -10,000 -4.23% ✗ $234.7K
Jun 9, 2021 Jun 11, 2021 Allogene Therapeutics, Inc. Director Sell 22.5 -9,969 -4.05% ✗ $249.7K
Oct 15, 2018 Oct 17, 2018 Allogene Therapeutics, Inc. Director Buy 92.5 +15,000 8.16% ✗ $270K